MINOR BREAKPOINT CLUSTER REGION (M-BCR) POSITIVE CHRONIC MYELOID-LEUKEMIA WITH AN ACUTE LYMPHOBLASTIC-LEUKEMIA ONSET - A CASE-REPORT

被引:16
作者
COSTELLO, RT
GABERT, J
BRUNEL, V
SAINTY, D
ARNOULET, C
MOZZICONACCI, MJ
CAMERLO, J
PERRET, C
GASTAUT, JA
BOUABDALLAH, R
LAFAGEPOCHITALOFF, M
机构
[1] INST J PAOLI I CALMETTES,DEPT BIOL,F-13009 MARSEILLE,FRANCE
[2] INST J PAOLI I CALMETTES,DEPT HAEMATOL,F-13009 MARSEILLE,FRANCE
[3] INSERM,U119,MARSEILLE,FRANCE
关键词
CHRONIC MYELOID LEUKEMIA; PHILADELPHIA CHROMOSOME; M-BCR; ACUTE LYMPHOBLASTIC LEUKEMIA; INTERFERON;
D O I
10.1111/j.1365-2141.1995.tb05317.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
m-BCR chronic myeloid leukaemia (CML) is a rare entity. We report a patient presenting with Philadelphia (Ph)-positive, m-BCR-positive acute lymphoblastic leukaemia (ALL) who achieved complete remission after induction chemotherapy, but showed a majority of Ph-positive mitoses during this remission, A diagnosis of m-BCR CML was established and the patient was given interferon a therapy. This is the first m-BCR CML presenting as ab initio ALL. This report emphasizes the importance of karyotyping Ph-positive ALL during remission so as not to misdiagnose CML patients who can benefit from Interferon therapy.
引用
收藏
页码:428 / 430
页数:3
相关论文
共 10 条
[1]   DIFFERENCES BETWEEN BLASTIC CHRONIC MYELOID-LEUKEMIA AND PH-POSITIVE ACUTE-LEUKEMIA [J].
BERGER, R .
LEUKEMIA & LYMPHOMA, 1993, 11 :235-237
[2]   ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A MULTICENTRIC RANDOMIZED TRIAL TESTING BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY [J].
FIERE, D ;
LEPAGE, E ;
SEBBAN, C ;
BOUCHEIX, C ;
GISSELBRECHT, C ;
VERNANT, JP ;
VARET, B ;
BROUSTET, A ;
CAHN, JY ;
RIGALHUGUET, F ;
WITZ, F ;
MICHAUX, JL ;
MICHALLET, M ;
REIFFERS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1990-2001
[3]  
GUO JQ, 1993, HEMATOL PATHOL, V7, P91
[4]   DIAGNOSIS OF CHRONIC MYELOID AND ACUTE LYMPHOCYTIC LEUKEMIAS BY DETECTION OF LEUKEMIA-SPECIFIC MESSENGER-RNA SEQUENCES AMPLIFIED INVITRO [J].
KAWASAKI, ES ;
CLARK, SS ;
COYNE, MY ;
SMITH, SD ;
CHAMPLIN, R ;
WITTE, ON ;
MCCORMICK, FP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5698-5702
[5]   DIFFERENCES IN ONCOGENIC POTENCY BUT NOT TARGET-CELL SPECIFICITY DISTINGUISH THE 2 FORMS OF THE BCR/ABL ONCOGENE [J].
KELLIHER, M ;
KNOTT, A ;
MCLAUGHLIN, J ;
WITTE, ON ;
ROSENBERG, N .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (09) :4710-4716
[6]  
MELO JV, 1994, LEUKEMIA, V8, P208
[7]   CONSISTENT INVOLVEMENT OF THE 3' HALF PART OF THE 1ST BCR INTRON IN ADULT PHILADELPHIA-POSITIVE LEUKEMIA WITHOUT M-BCR REARRANGEMENT [J].
NAKAMURA, Y ;
HIROSAWA, S ;
AOKI, N .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (01) :53-57
[8]   MOLECULAR RELAPSE IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION DETECTED BY POLYMERASE CHAIN-REACTION [J].
SAWYERS, CL ;
TIMSON, L ;
KAWASAKI, ES ;
CLARK, SS ;
WITTE, ON ;
CHAMPLIN, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :563-567
[9]  
SELLERI L, 1990, BLOOD, V75, P1146
[10]  
ZACCARIA A, 1990, BLOOD, V76, P1663